Cadrenal Therapeutics, Inc. Stock Issued During Period, Value, Other
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Cadrenal Therapeutics, Inc. stock issued during period, value, other for the quarter ending 2026-06-30 was $366.56K.
- Cadrenal Therapeutics, Inc. stock issued during period, value, other for the quarter ending 2024-09-30 was $1.53M.
- Cadrenal Therapeutics, Inc. stock issued during period, value, other for the quarter ending 2023-12-31 was -$11.90M.
- Cadrenal Therapeutics, Inc. stock issued during period, value, other for fiscal 2023 was -$6.49M.
| Period end | Stock Issued During Period, Value, Other 3 month | Stock Issued During Period, Value, Other 12 month |
|---|---|---|
| 2026-06-30 | $366.56K 10-Q · filed 2026-08-13 | |
| 2024-09-30 | $1.53M 10-Q · filed 2024-11-07 | |
| 2023-12-31 | -$11.90M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-11 | -$6.49M 10-K · filed 2024-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B |